Table of Contents Author Guidelines Submit a Manuscript
Advances in Orthopedics
Volume 2016 (2016), Article ID 3703482, 7 pages
http://dx.doi.org/10.1155/2016/3703482
Clinical Study

Effects of Zoledronate on Mortality and Morbidity after Surgical Treatment of Hip Fractures

1Department of Orthopedics and Traumatology, Faculty of Medicine, Bezmialem University, Fatih, 34050 Istanbul, Turkey
2Department of Orthopedics and Traumatology, Istanbul Faculty of Medicine, Istanbul University, Çapa Fatih, 34050 Istanbul, Turkey
3Muş State Hospital, Department of Orthopedics and Traumatology, 49100 Muş, Turkey
4Department of Orthopedics and Traumatology, Istanbul Medipol University, Bağcılar, 34214 Istanbul, Turkey

Received 7 December 2015; Revised 14 February 2016; Accepted 2 March 2016

Academic Editor: Robert F. Ostrum

Copyright © 2016 Ömer Cengiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Jacobsen, J. Goldberg, T. P. Miles, J. A. Brody, W. Stiers, and A. A. Rimm, “Hip fracture incidence among the old and very old: a population-based study of 745,435 cases,” American Journal of Public Health, vol. 80, no. 7, pp. 871–873, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Boonen, P. Autier, M. Barette, D. Vanderschueren, P. Lips, and P. Haentjens, “Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study,” Osteoporosis International, vol. 15, no. 2, pp. 87–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Colón-Emeric, M. Kuchibhatla, C. Pieper et al., “The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies,” Osteoporosis International, vol. 14, no. 11, pp. 879–883, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. T. Canale, Campbell's Operative Orthopaedics, vol. 3, Güneş Tıp Kitabevleri, 11th edition, 2011, Turkish Translation Edited by M. Basbozkurt, C. Yıldız.
  5. R. Ege, Kalça Cerrahisi ve Sorunları, THK Basımevi, Ankara, Turkey, 1994.
  6. J. Melton and C. Cooper, “Magnitude and impact of osteoporosis and fractures,” in Osteoporosis, R. Marcus, D. D. Feldman, and J. Kelsey, Eds., vol. 1, pp. 557–567, Academic Press, San Diego, Calif, USA, 2001. View at Google Scholar
  7. M. J. Gardner, R. H. Brophy, D. Demetrakopoulos et al., “Interventions to improve osteoporosis treatment following hip fracture: a prospective, randomized trial,” The Journal of Bone & Joint Surgery—American Volume, vol. 87, no. 1, pp. 3–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. S. Colón-Emeric, K. W. Lyles, P. House et al., “Randomized trial to improve fracture prevention in nursing home residents,” The American Journal of Medicine, vol. 120, no. 10, pp. 886–892, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Lieberman, “Fracture of the hip,” in AAOS Comprehensive Orthopaedic Review, chapter 55, pp. 597–610, American Academy of Orthopaedic Surgeons, Rosemont, Ill, USA, 2009. View at Google Scholar
  10. G. M. Orosz, J. Magaziner, E. L. Hannan et al., “Association of timing of surgery for hip fracture and patient outcomes,” The Journal of the American Medical Association, vol. 291, no. 14, pp. 1738–1743, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. N. Villar, S. M. Allen, and S. J. Barnes, “Hip fractures in healthy patients: operative delay versus prognosis,” The British Medical Journal, vol. 293, no. 6556, pp. 1203–1204, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Paksima, K. J. Koval, G. B. Aharanoff et al., “Predictors of mortality after hip fracture: a 10-year prospective study,” Bulletin of the NYU Hospital for Joint Diseases, vol. 66, no. 2, pp. 111–117, 2008. View at Google Scholar · View at Scopus
  13. N. S. Weiss, J. M. Liff, C. L. Ure, J. H. Ballard, G. H. Abbott, and J. R. Daling, “Mortality in women following hip fracture,” Journal of Chronic Diseases, vol. 36, no. 12, pp. 879–882, 1983. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Black, P. D. Delmas, R. Eastell et al., “Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis,” The New England Journal of Medicine, vol. 356, no. 18, pp. 1809–1822, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Green, “Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies,” Seminars in Oncology, vol. 28, no. 2, supplement 6, pp. 4–10, 2001. View at Google Scholar · View at Scopus
  16. F. J. A. Penning-van Beest, J. A. Erkens, M. Olson, and R. M. C. Herings, “Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis,” Current Medical Research and Opinion, vol. 24, no. 5, pp. 1337–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. S. Siris, S. T. Harris, C. J. Rosen et al., “Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases,” Mayo Clinic Proceedings, vol. 81, no. 8, pp. 1013–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. F. Eriksen, K. W. Lyles, C. S. Colón-Emeric et al., “Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture,” Journal of Bone and Mineral Research, vol. 24, no. 7, pp. 1308–1313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Dawson-Hughes, G. E. Dallal, E. A. Krall, L. Sadowski, N. Sahyoun, and S. Tannenbaum, “A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women,” The New England Journal of Medicine, vol. 323, no. 13, pp. 878–883, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. R. R. Recker, S. Hinders, K. M. Davies et al., “Correcting calcium nutritional deficiency prevents spine fractures in elderly women,” Journal of Bone and Mineral Research, vol. 11, no. 12, pp. 1961–1966, 1996. View at Google Scholar · View at Scopus
  21. R. W. Bucholz, Rockwood and Green's Fractures in Adults, vol. 2, Güneş Tıp Kitabevleri, 6th edition, 2011, Translation Edited by U. Saylı.
  22. D. B. Browner, J. B. Jupiter, A. M. Levine, and P. G. Trafton, Skeletal Trauma, vol. 2, WB Saunders Company, Philadelphia, Pa, USA, 1833.
  23. R. Smektala, H. G. Endres, B. Dasch et al., “The effect of time-to-surgery on outcome in elderly patients with proximal femoral fractures,” BMC Musculoskeletal Disorders, vol. 9, article 171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Richmond, G. B. Aharonoff, J. D. Zuckerman, and K. J. Koval, “Mortality risk after hip fracture,” Journal of Orthopaedic Trauma, vol. 17, no. 8, supplement, pp. 53–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. İ. Öztürk, S. Toker, E. Ertürer, B. Aksoy, and F. Seçkin, “Analysis of risk factors affecting mortality in elderly patients (aged over 65 years) operated on for hip fractures,” Acta Orthopaedica et Traumatologica Turcica, vol. 42, no. 1, pp. 16–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. R. Cummings, D. M. Black, M. C. Nevitt et al., “Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group,” The Lancet, vol. 341, no. 8837, pp. 72–75, 1993. View at Publisher · View at Google Scholar
  27. J. E. Kenzora, R. E. McCarthy, J. D. Lowell, and C. B. Sledge, “Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications,” Clinical Orthopaedics and Related Research, vol. 186, pp. 45–56, 1984. View at Google Scholar
  28. J. O. Lawton, M. R. Baker, and R. A. Dickson, “Femoral neck fractures-two populations,” The Lancet, vol. 322, no. 8341, pp. 70–72, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. W.-P. Lin, C.-J. Wen, C.-C. Jiang, S.-M. Hou, C.-Y. Chen, and J. Lin, “Risk factors for hip racture sites and mortality in older adults,” Journal of Trauma-Injury Infection & Critical Care, vol. 71, no. 1, pp. 191–197, 2011. View at Publisher · View at Google Scholar
  30. C.-B. Wang, C.-F. J. Lin, W.-M. Liang et al., “Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study,” Bone, vol. 56, no. 1, pp. 147–153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Broderick, R. Bruce-Brand, E. Stanley, and K. J. Mulhall, “Osteoporotic hip fractures: the burden of fixation failure,” The Scientific World Journal, vol. 2013, Article ID 515197, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Knobe, R. Münker, R. M. Sellei et al., “Unstable pertrochanteric femur fractures. Failure rate, lag screw sliding and outcome with extra- and intramedullary devices (PCCP, DHS and PFN),” Zeitschrift für Orthopädie und Unfallchirurgie, vol. 147, no. 3, pp. 306–313, 2009. View at Google Scholar · View at Scopus
  33. I. R. Reid, J. P. Brown, P. Burckhardt et al., “Intravenous zoledronic acid in postmenopausal women with low bone mineral density,” The New England Journal of Medicine, vol. 346, no. 9, pp. 653–661, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Grey, M. J. Bolland, A. Horne et al., “Five years of anti-resorptive activity after a single dose of zoledronate—results from a randomized double-blind placebo-controlled trial,” Bone, vol. 50, no. 6, pp. 1389–1393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Grey, M. Bolland, S. Wong, A. Horne, G. Gamble, and I. R. Reid, “Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 1, pp. 286–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Kawashima and H. K. Uhthoff, “Pattern of bone loss of the proximal femur: a radiologic, densitometric, and histomorphometric study,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 634–640, 1991. View at Publisher · View at Google Scholar · View at Scopus
  37. R. L. Prince, E. Geelhoed, T. Harris, R. Hockey, R. Price, and M. Smith, “Screening for osteoporosis by bone densitometry: a stratified intervention approach,” Osteoporosis International, vol. 3, supplement 1, pp. 75–77, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. D. J. Sartoris, “Clinical value of bone densitometry,” American Journal of Roentgenology, vol. 163, no. 1, pp. 133–135, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. M. McClung, R. Recker, P. Miller et al., “Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate,” Bone, vol. 41, no. 1, pp. 122–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Bai, D. Jing, A. Guo, and S. Yin, “Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women,” Journal of International Medical Research, vol. 41, no. 3, pp. 697–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Matta, “Fractures of the acetabulum: accuracy of reduction and clinical results in patients managed operatively within three weeks after the injury,” The Journal of Bone & Joint Surgery—American Volume, vol. 78, no. 11, pp. 1632–1645, 1996. View at Google Scholar · View at Scopus
  42. W. H. Harris, “Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end result study using a new method of result evaluation,” The Journal of Bone & Joint Surgery—American Volume, vol. 51, no. 4, pp. 737–755, 1969. View at Google Scholar · View at Scopus
  43. N. Amanat, M. McDonald, C. Godfrey, L. Bilston, and D. Little, “Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair,” Journal of Bone and Mineral Research, vol. 22, no. 6, pp. 867–876, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. C. T. Hopkins, J. T. Nugent, and J. H. Dimon III, “Medial displacement osteotomy for unstable intertrochanteric fractures. Twenty years later,” Clinical Orthopaedics and Related Research, no. 245, pp. 169–172, 1989. View at Google Scholar · View at Scopus
  45. C. G. Moran, R. T. Wenn, M. Sikand, and A. M. Taylor, “Early mortality after hip fracture: is delay before surgery important?” The Journal of Bone & Joint Surgery—American Volume, vol. 87, no. 3, pp. 483–489, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Haentjens, P. Autier, M. Barette, K. Venken, D. Vanderschueren, and S. Boonen, “Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture,” Bone, vol. 41, no. 6, pp. 958–964, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Kopp, K. Edelmann, P. Obruba, B. Procházka, K. Blšťáková, and V. Džupa, “Mortality risk factors in the elderly with proximal femoral fracture treated surgically,” Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, vol. 76, no. 1, pp. 41–46, 2009. View at Google Scholar · View at Scopus
  48. P. Douša, O. Čech, M. Weissinger, and V. Džupa, “Trochanteric femoral fractures,” Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, vol. 80, no. 1, pp. 15–26, 2013. View at Google Scholar · View at Scopus
  49. C. W. Davidson, M. J. Merrilees, T. J. Wilkinson, J. S. McKie, and N. L. Gilchrist, “Hip fracture mortality and morbidity—can we do better?” New Zealand Medical Journal, vol. 114, pp. 329–332, 2001. View at Google Scholar
  50. N. F. Ray, J. K. Chan, M. Thamer, and L. J. Melton III, “Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation,” Journal of Bone and Mineral Research, vol. 12, no. 1, pp. 24–35, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. I. C. Vossinakis and L. S. Badras, “The external fixator compared with the sliding hip screw for pertrochanteric fractures of the femur,” The Journal of Bone & Joint Surgery—British Volume, vol. 84, no. 1, pp. 23–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. J. O. Lawton, M. R. Baker, and R. A. Dickson, “Femoral neck fractures—two populations,” The Lancet, vol. 322, no. 8341, pp. 70–72, 1983. View at Publisher · View at Google Scholar · View at Scopus
  53. N. M. Maalouf, H. J. Heller, C. V. Odvina, P. J. Kim, and K. Sakhaee, “Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature,” Endocrine Practice, vol. 12, no. 1, pp. 48–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. K. W. Lyles, C. S. Colón-Emeric, J. S. Magaziner et al., “Zoledronic acid and clinical fractures and mortality after hip fracture,” The New England Journal of Medicine, vol. 357, pp. 1799–1809, 2007. View at Publisher · View at Google Scholar